In this study, we provide the first evidence that adipocytes are capable of activating SphK2 and unravel a previously unrecognized role of SphK2 in the adipocyte-induced growth-promoting action in ovarian cancer. This evidence concerns the gene SPHK2 and ovarian carcinoma.